The full scientific programme for the 2026 ‘From Insight to Decision’ e-symposium, which is taking place on 2 and 8 December, has been announced by CN Bio. The event will feature expert-led sessions offering practical, real-world guidance on organ-on-a-chip (OOC) use within existing R&D strategies. Launched in… Read More
Kelsey Jakee, Senior Director, Portfolio Strategy & Innovation at TransCelerate BioPharma, argues why advances in clinical R&D won’t solely be dependent on technology. Every… Read More
Nxera Pharma has received $10 million after a fourth R&D milestone was met in the company’s collaboration with AbbVie. Nxera and AbbVie entered a multi-target collaboration in 2022 to leverage Nxera’s NxWave platform to discover novel medicines targeting G protein-coupled receptors (GPCRs) associated with neurological disease. The fourth… Read More
A new UK research centre has opened to accelerate the search for treatments for Parkinson’s disease. The £10 million ($13.5 million) UK Dementia Research Institute Parkinson’s Research Centre, jointly funded with Parkinson’s UK, will connect research teams at the University of Edinburgh, the University of Oxford and University College London. Read More
The use of artificial intelligence is widespread across life sciences organisations but its use in drug research and development is limited, analysis finds. Research by The Pistoia Alliance, a not-for-profit life sciences advocacy group, shows 30% of life sciences professionals say their organisation has implemented an enterprise-wide AI… Read More
A chemistry synthesis laboratory entirely operated and led by women scientists has opened in India. ChemiSHE, launched by CRDMO Aragen, was inaugurated on 8 April at Aragen’s Mallapur campus in Hyderabad. Aragen says ChemiSHE is part of a broader strategic initiative to strengthen gender diversity across the company’s scientific workforce and create structured… Read More
Research and development in medical dermatology is set to be advanced by supercomputing and artificial intelligence. Biopharmaceutical company Almirall has announced an expanded collaboration with the Barcelona Supercomputing Center (BSC), aiming to address the needs of patients with skin conditions. The partnership builds on previous successful R&D joint… Read More
Bruntwood SciTech and Thermo Fisher Scientific have entered into a new strategic collaboration to support businesses across Bruntwood SciTech’s national portfolio of life science campuses, with a particular focus at their Alderley Park campus in Cheshire – the UK’s largest single site life science campus, which is home to… Read More
This is the latest episode of the free DDW narrated podcast, “Challenges and tactics for transformative drug development”. It covers two articles written for Volume 23, Issue 2 – Spring 2022 of DDW. They are called “Balancing speed and quality in CLD for faster drug development”, and… Read More
A cloud-based digital pathology platform has helped a CRO deliver more informed preclinical studies. Proscia announced that Virscio, a provider of translational research and development services, has deployed Concentriq for Research. Context 90% of drug candidates fail during clinical trials.1 This… Read More
This is the latest episode of the free DDW podcast, “Complex problems require complex solutions”. It covers two articles written for Volume 23, Issue 1 – Winter 2021/22 of DDW. They are called “How quantum computing can benefit drug discovery” and “Sitting down with Dr Michael Hayden from… Read More
The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has launched a new Community of Experts (CoE) with the aim of harnessing real-world data (RWD) from social media. The organisation is calling on technology companies, data scientists and RWD experts to join… Read More
A new partnership will bring together Microsoft’s computational services, cloud and artificial intelligence (AI) and Novo Nordisk’s drug discovery, development and data science capabilities. Through the agreement, Microsoft will provide AI technology, foundational science models and expertise and work alongside Novo Nordisk’s data scientists and domain experts to accelerate the… Read More
BioIVT has acquired XenoTech, a provider of products and services for preclinical testing that specialises in ADME, DMPK and DDI testing of potential drug candidates. Through the acquisition, BioIVT aims to expand the portfolio of research models and services that are available to its clients to support… Read More
Benchling has launched its first full set of capabilities for designing, modeling, and studying both natural and chemically modified RNA in a single solution. As the biopharmaceutical industry increases its focus on developing RNA therapeutics, the new RNA solution could help R&D organisations accelerate the delivery of drug candidates. Following… Read More
Merck has opened a new Launch and Technology Center for healthcare in Darmstadt, costing the company around €160 million. This is part of a planned investment of more than €1.5 billion at the global headquarters in Darmstadt by 2025. The Launch and Technology Center will bridge research and commercial production… Read More
